Back to search

United Kingdom· GB-APID-5531011000001103

Celance 50microgram tablets

A pergolide product containing pergolide, registered in United Kingdom by Dowelhurst Ltd. The same ATC class is registered in 3 of our 19 countries.

ATC N04BC02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCelance 50microgram tabletsATCN04BC02REGISTER NO.GB-APID-5531011000001…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Pergolide is registered in 3 of 19 countries.

Countries holding a registration under ATC N04BC02 (pergolide), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 1 of them publish a price we can compare per daily dose

Pergolide · ATC N04BC02

3 / 19 countries

  • Finlandprice
  • Japan
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Pergolide
Manufacturer
Dowelhurst Ltd
Country
United Kingdom (GB)
ATC code
N04BC02
ATC class
Pergolide
Defined daily dose
3 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for pergolide.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pergolide · interactions on record

81 records

  • 1 severe
  • 55 moderate
  • 25 info

Most severe, free to view

  • LorcaserinA08AA11severe
  • MetoclopramideA03FA01moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pergolide in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pergolide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ac4a01db-bc07-42a0-8c9f-1a112decfb7d
GET /v1/drugs/ac4a01db-bc07-42a0-8c9f-1a112decfb7d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "5531011000001103",
  "desc": "Celance 50microgram tablets (Dowelhurst Ltd)",
  "form": "Oral tablet",
  "vpid": "39702411000001100",
  "source": "dmd",
  "vtm_id": "777139007",
  "strength": "50 microgram",
  "substance": "Pergolide",
  "ingredient": "Pergolide mesilate",
  "supplier_code": "5283211000001105"
}

See everything about pergolide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.